Other

Seoul National University

Snu Rdb Foundation

Korea Research Institute of Bioscience and Biotechnology

National Cancer Center

Cellbion Co., Ltd

June-Key Chung

Dong Soo Lee

Jae Min Jeong

Myung Chul Lee

Jae-ho Lee

Se Hun Kang

Seok Ki Kim

Yun-Sang Lee

Young Ju Kim

Yoonkyung Kim

Hyun-Sook Park

Woo-Ho Kim

Hye-Seung Han

Ying Yuan

Jae-Gahb Park

Ju Young Heo

Young Kyoung Lee

Young-Hwa Kim

Dinesh Shetty

Soon-Beom Kang

The present invention relates to a nanoparticle having a linker connected to a long alkane or alkene chain, and a method for preparing the nanoparticle. The alkyl chain of Cintroduced with a ligand of the present invention can be coated on a hydrophobic nanoparticle through a noncovalent bond, enabling easy introduction of various ligands to the nanoparticle, and the nanoparticle having various functional groups prepared using the method can be applied to fluorescent detection, MRI, raman spectroscopy, optical detection, PET, SPECT, or gamma image device, and the ligand of the visualization agents can be modified to be used for new vessels detection, cancer cell detection, immunocyte detection, hepatocyte detection, cell death detection, and gene detection.

Nanoparticle coated with ligand introduced with long hydrophobic chain and method for preparing same

Disclosed herein is a method of improving tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting, and the multivalent ligands for tumor diagnosis.

Method to improve the tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting

The present invention relates to a triazanonane derivative indicated by the chemical formula 1 below, or a pharmaceutically acceptable salt thereof, and a method for preparing same, and the triazanonane derivative according to the present invention forms a complex with a metal-fluoride and displays an effect of increasing the labeling efficiency up to 78-90% when labeling F-18, thus enabling use in various radioactive medicine labeling (In the chemical formula 1, R, R, A. E. X, n and m are as defined in the present description.)

Triazanonane derivatives or pharmaceutically acceptable salt thereof for enhanced fluorine-18 labeling

The present invention relates to a novel diaminedithiol derivative or a pharmaceutically acceptable salt thereof; radiorhenium or radiotechneticum complex thereof; a composition for treating liver cancer comprising the radiorhenium complex and lipiodol; and, a preparative kit of the composition for treating liver cancer. In the composition according to the invention, the diaminedithiol derivative is a novel compound in which long chain alkyl groups were introduced to diaminedithiol, capable of forming a radiorhenium or radiotechnetium complex thereof with an ease and leading to stronger van der Waals bonds with lipiodol. As a result, the complex becomes more stable in a medium, lipiodol, whereby the composition of the invention exhibits a high accumulation rate in liver cancer tissue when injected via hepatic artery, thereby capable of achieving an efficient treatment of liver cancer.

Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition

A human ovarian carcinoma cell line having an in-frame 3-bp deletion at codons 255 and 256 in exon 7 of the p53 gene, a nonsense mutation of codon 1815 in exon 23 of the BRCA1 gene, and a missense mutation of codon 723 in exon 19 of the hMLH1 gene.

Human ovarian carcinoma cell lines

Growing community of inventors

Seoul, South Korea

June-Key Chung